<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Using a micromethod, hepatic <z:chebi fb="0" ids="16990">bilirubin</z:chebi> <z:chebi fb="15" ids="17659">UDP</z:chebi>-glucuronyl transferase has been assayed in percutaneous needle biopsy samples obtained from patients with infectious <z:hpo ids='HP_0012115'>hepatitis</z:hpo>, postnecrotic <z:hpo ids='HP_0001394'>cirrhosis</z:hpo>, <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's disease</z:e>, noncirrhotic <z:hpo ids='HP_0006580'>portal fibrosis</z:hpo> (NCPF), granuloma of the liver, and extrahepatic <z:e sem="disease" ids="C0265029" disease_type="Disease or Syndrome" abbrv="">portal vein obstruction</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The results were compared with those obtained from 10 control subjects </plain></SENT>
<SENT sid="2" pm="."><plain>Patients with <z:hpo ids='HP_0001394'>cirrhosis</z:hpo> and infectious <z:hpo ids='HP_0012115'>hepatitis</z:hpo> revealed <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="0" ids="16990">bilirubin</z:chebi> transferase levels, whereas those with <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's disease</z:e> showed significantly low enzyme levels </plain></SENT>
<SENT sid="3" pm="."><plain>Many patients with NCPF, some with extrahepatic <z:e sem="disease" ids="C0265029" disease_type="Disease or Syndrome" abbrv="">portal vein obstruction</z:e>, and patients with granulomatous involvement of the liver demonstrated significantly low levels </plain></SENT>
<SENT sid="4" pm="."><plain>This low hepatitic-enzyme activity was not associated with <z:hpo ids='HP_0002904'>hyperbilirubinemia</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>The mechanism of such low values in NCPF and other disorders is not known </plain></SENT>
<SENT sid="6" pm="."><plain>It is postulated that low heaptic-enzyme activity in noncirrhotic <z:hpo ids='HP_0006580'>portal fibrosis</z:hpo> is due to sparse smooth endoplasmic reticulum </plain></SENT>
<SENT sid="7" pm="."><plain>This study also emphasizes that serum <z:chebi fb="0" ids="16990">bilirubin</z:chebi> may remain <z:mpath ids='MPATH_458'>normal</z:mpath> with very low hepatic-enzyme activity </plain></SENT>
<SENT sid="8" pm="."><plain>Although induction of the microsomal enzyme <z:chebi fb="0" ids="16990">bilirubin</z:chebi> transferase was observed following <z:chebi fb="0" ids="8069">phenobarbitone</z:chebi> administration in noncirrhotic <z:hpo ids='HP_0006580'>portal fibrosis</z:hpo>, this was not apparent in patients with <z:hpo ids='HP_0001394'>cirrhosis</z:hpo>, possibly due to maximal enzyme induction having been achieved by endogenous substrate </plain></SENT>
</text></document>